SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Make a comment > Terms and Conditions

  1. When posting or reading you agree:
    1. To accept full responsibility for the views you contribute.
    2. To use this function only for lawful purposes.
    3. Not to post defamatory, abusive, offensive, racist, sexist, threatening, vulgar, obscene, hateful or otherwise inappropriate comments, or to post comments which will constitute a criminal offence or give rise to civil liability.
    4. Not to post or make available any material which is protected by copyright, trade mark or other proprietary right without the express permission of the owner of the copyright, trade mark or any other proprietary right.
    5. Not to post any content that is advertising related.
    6. To evaluate for yourself the accuracy of any opinion, advice or other content.
    7. To supply your name and e mail address.
  2. Complaints
    1. You wish to complain about any content please use the "Report Abuse" feature and include details of your complaint, what action you would like us to take and how we can contact you.
  3. Monitoring
    1. Contributions to Make A Comment will be moderated before being published. If our attention is drawn to allegedly inappropriate content we reserve the right remove the material or the comment.
    2. Comments displaying advertising material will not be published.
    3. We reserve the right not to publish comments. Correspondence with contributors over comments which have been declined for publication will not be entertained.
  4. General
    1. We reserve the right to reveal your identity and contact details to third parties if we believe that you may have breached any of our terms and conditions.
    2. By posting material on Make a Comment, you grant all other users the right to obtain access to this material.
    3. You acknowledge that the author of each contribution is responsible for his or her comments.
    4. We are not responsible for the accuracy, veracity or reliability of any opinion, advice or statement made on Make A Comment unless it is edited by us. If un-modified by us, contributions shall not be considered to be reviewed, edited or approved by William Reed Business Media.
    5. Readers are asked to keep their comments concise and relevant to the topic in question.

Spotlight

SCM's woes part of UK-wide aseptic slowdown, says ex-owner

SCM's woes part of UK-wide aseptic slowdown, says ex-owner

GMP failures at an aseptic plant owned by SCM Pharma are part of a wider industry trend...

Boehringer aims to cut German costs 15% as H1 sales fall

Boehringer Ingelheim aims to cut German costs 15% as revenues drop

German jobs are safe despite a programme that will cut the cost of operations by 15%, Boehringer...

WHO: Data from use of unapproved Ebola drugs should be shared

WHO: Data from use of unapproved Ebola drugs should be shared

Efficacy and safety data from use of unapproved Ebola virus treatments should be shared according to an...

THC may reduce tumor size? mouse study investigates

THC may reduce tumor size? mouse study investigates

A previously unknown signaling platform may be responsible for the success of the main psychoactive ingredient in...

India’s CDSCO outlines procedures for state manufacturer inspections

India’s CDSCO outlines procedures for state inspections of manufacturers

In order to ensure uniformity on the state and federal levels, India’s CDSCO (Central Drugs Standard Control...

Roche re-enters RNAi space with $250m Santaris acquisition

Roche re-enters gene silencing space with $250m LNA acquisition

Roche has renewed its interest in gene silencing drugs, paying $250m (€187m) for Santaris Pharma including its...

Key Industry Events

 

Access all events listing

Our events, Events from partners...